You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: October 4, 2024

AMZEEQ Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


Which patents cover Amzeeq, and when can generic versions of Amzeeq launch?

Amzeeq is a drug marketed by Journey and is included in one NDA. There are twelve patents protecting this drug and one Paragraph IV challenge.

This drug has twenty-five patent family members in ten countries.

The generic ingredient in AMZEEQ is minocycline hydrochloride. There are fifteen drug master file entries for this compound. Thirty-four suppliers are listed for this compound. Additional details are available on the minocycline hydrochloride profile page.

DrugPatentWatch® Litigation and Generic Entry Outlook for Amzeeq

A generic version of AMZEEQ was approved as minocycline hydrochloride by WATSON LABS on December 30th, 1991.

  Sign Up

AI Research Assistant
Questions you can ask:
  • What is the 5 year forecast for AMZEEQ?
  • What are the global sales for AMZEEQ?
  • What is Average Wholesale Price for AMZEEQ?
Drug patent expirations by year for AMZEEQ
Drug Prices for AMZEEQ

See drug prices for AMZEEQ

Recent Clinical Trials for AMZEEQ

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Vyne Therapeutics Inc.Phase 4
Edward Lain, MDPhase 4

See all AMZEEQ clinical trials

Pharmacology for AMZEEQ
Paragraph IV (Patent) Challenges for AMZEEQ
Tradename Dosage Ingredient Strength NDA ANDAs Submitted Submissiondate
AMZEEQ Topical Aerosol Foam minocycline hydrochloride 4% 212379 1 2021-05-11

US Patents and Regulatory Information for AMZEEQ

AMZEEQ is protected by twelve US patents.

Patents protecting AMZEEQ

Topical tetracycline compositions
Patent Number: ⤷  Sign Up
Patent Expiration: ⤷  Sign Up
Patented Use: TREATMENT OF NON-NODULAR ACNE VULGARIS

Surfactant-free water-free foamable compositions, breakable foams and gels and their uses
Patent Number: ⤷  Sign Up
Patent Expiration: ⤷  Sign Up
Patented Use: TREATMENT OF NON-NODULAR ACNE VULGARIS

Topical tetracycline compositions
Patent Number: ⤷  Sign Up
Patent Expiration: ⤷  Sign Up
Patented Use: TREATMENT OF NON-NODULAR ACNE VULGARIS

Compositions, gels and foams with rheology modulators and uses thereof
Patent Number: ⤷  Sign Up
Patent Expiration: ⤷  Sign Up

Compositions and methods for treating rosacea and acne
Patent Number: ⤷  Sign Up
Patent Expiration: ⤷  Sign Up
Patented Use: TREATMENT OF NON-NODULAR ACNE VULGARIS

Method for healing of an infected acne lesion without scarring
Patent Number: ⤷  Sign Up
Patent Expiration: ⤷  Sign Up
Patented Use: TREATMENT OF NON-NODULAR ACNE VULGARIS


Patent Number: ⤷  Sign Up
Patent Expiration: ⤷  Sign Up
Patented Use: TREATMENT OF NON-NODULAR ACNE VULGARIS

Compositions and methods for treating rosacea and acne
Patent Number: ⤷  Sign Up
Patent Expiration: ⤷  Sign Up
Patented Use: TREATMENT OF NON-NODULAR ACNE VULGARIS

Topical tetracycline compositions
Patent Number: ⤷  Sign Up
Patent Expiration: ⤷  Sign Up
Patented Use: TREATMENT OF NON-NODULAR ACNE VULGARIS

Surfactant-free water-free foamable compositions, breakable foams and gels and their uses
Patent Number: ⤷  Sign Up
Patent Expiration: ⤷  Sign Up

Topical tetracycline compositions
Patent Number: ⤷  Sign Up
Patent Expiration: ⤷  Sign Up
Patented Use: TREATMENT OF NON-NODULAR ACNE VULGARIS

Topical tetracycline compositions
Patent Number: ⤷  Sign Up
Patent Expiration: ⤷  Sign Up
Patented Use: TREATMENT OF NON-NODULAR ACNE VULGARIS

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Journey AMZEEQ minocycline hydrochloride AEROSOL, FOAM;TOPICAL 212379-001 Oct 18, 2019 RX Yes Yes ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Journey AMZEEQ minocycline hydrochloride AEROSOL, FOAM;TOPICAL 212379-001 Oct 18, 2019 RX Yes Yes ⤷  Sign Up ⤷  Sign Up Y ⤷  Sign Up
Journey AMZEEQ minocycline hydrochloride AEROSOL, FOAM;TOPICAL 212379-001 Oct 18, 2019 RX Yes Yes ⤷  Sign Up ⤷  Sign Up Y ⤷  Sign Up
Journey AMZEEQ minocycline hydrochloride AEROSOL, FOAM;TOPICAL 212379-001 Oct 18, 2019 RX Yes Yes ⤷  Sign Up ⤷  Sign Up Y ⤷  Sign Up
Journey AMZEEQ minocycline hydrochloride AEROSOL, FOAM;TOPICAL 212379-001 Oct 18, 2019 RX Yes Yes ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

International Patents for AMZEEQ

See the table below for patents covering AMZEEQ around the world.

Country Patent Number Title Estimated Expiration
Australia 2015224534 SURFACTANT-FREE WATER-FREE FOAMABLE COMPOSITIONS, BREAKABLE FOAMS AND GELS AND THEIR USES ⤷  Sign Up
Israel 218866 תרכובות, נטולות חומר פעיל שטח ונטולות מים, הניתנות להקצפה, קצפים שבירים ושימושיהם (Surfactant-free, water-free, foamable compositions and breakable foams and their uses) ⤷  Sign Up
Mexico 2012003985 COMPOSICIONES TOPICAS TETRACICLINA. (TOPICAL TETRACYCLINE COMPOSITIONS.) ⤷  Sign Up
Canada 2776366 COMPOSITIONS MOUSSANTES SANS EAU ET SANS SURFACTANT, MOUSSES ET GELS FRIABLES, AINSI QUE LEURS UTILISATIONS (SURFACTANT-FREE WATER-FREE FOAMABLE COMPOSITIONS, BREAKABLE FOAMS AND GELS AND THEIR USES) ⤷  Sign Up
Canada 2776471 COMPOSITIONS MOUSSANTES DEPOURVUES D'AGENT TENSIOACTIF ET D'EAU ET MOUSSES CASSABLES ET LEURS UTILISATIONS (SURFACTANT-FREE, WATER-FREE, FOAMABLE COMPOSITIONS AND BREAKABLE FOAMS AND THEIR USES) ⤷  Sign Up
>Country >Patent Number >Title >Estimated Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.